Milestone Pharmaceuticals (MIST)

• Market cap: $177M
• 1 day: -1.39%
• 5 days: -5.33%
• 1 month: -21.98%
• 3 months: -17.92%
• 6 months: -47.21%
• Year to date: -30.73%
• 1 year: -10.69%
• 5 years: -75.64%
• 10 years: -90.76%
• Sector: Healthcare
• Industry: Biotechnology

About: Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Employees: 38